Ms. Catherine T. Doherty serves as Senior Vice President Clinical Franchises of Quest Diagnostics Inc. She is responsible for overseeing the development of service offerings in the areas of cardiovascular, infectious disease, neurology, prescription drugs monitoring, women' health and general wellness. She also is responsible for the Care 360 connectivity program. From May 2011 to January 2013, she served as Senior Vice President, Physician services. From 2008 through May 2011 Ms. Doherty served as Vice President, Hospital Services. Prior to 2008, Ms. Doherty held a variety of positions of increasing responsibility since joining the Company in 1990, including Vice President, Office of the Chairman; Vice President, Finance and Administration for the Hospital business; Vice President, Investor Relations; and Chief Accounting Officer.
Sr. VP of Clinical Franchises
Age: 49 SVP Since 2013
The company has Return on Asset of 8.32 % which means that on every $100 spent on asset it made $8.32 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.37 % implying that it generated $15.37 on every 100 dollars invested.
The company has 3.4 B in debt with debt to equity (D/E) ratio of 0.8 which is OK given its current industry classification. Quest Diagnostics Inc has Current Ratio of 1.19 demonstrating that it is not liquid enough and may have problems to pay out its financial commitments when the payables are due.
Entity SummaryQuest Diagnostics Incorporated offer diagnostic testing information services in the United States and internationally. Quest Diagnostics Inc [DGX] is traded on New York Stock Exchange in USA. It is located in Madison, NJ and employs 41,000 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| DGX NYSE
Quest Diagnostics Inc
Quest Diagnostics Inc has less than 39.38 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Quest price boundaries
Promote Quest and Catherine Doherty